Evidence map›Paper›PMID 39019496›Full record

ArticleHeart (British Cardiac Society)2024

Evaluation of the World Health Organization-HEARTS hypertension control package in Bangladesh: a quasi-experimental trial.

Ahmad Abrar, Xiao Hu, Jubaida Akhtar, Shamim Jubayer, Mohammad Noor Nabi Sayem, Sarmin Sultana, Mohammad Abdullah Al Mamun, Mahfuzur Rahman Bhuiyan, Fazila Malik, Mohammad Robed Amin and 10 more

Registry-linked trialAbstract readMulticenter Study
In one paragraph

Article in Heart (British Cardiac Society), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04992039 (Evaluation of the WHO HEARTS Hypertension Control Package in the Primary Care Clinics of Bangladesh), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04992039 nacompletednot on this map

Evaluation of the WHO HEARTS Hypertension Control Package in the Primary Care Clinics of Bangladesh: A Quasi-experimental Trial

TypeinterventionalSponsorNational Heart Foundation of BangladeshRan2021 to 2022Enrolled3,935ConditionsHypertensionArmsWHO HEARTS technical package
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Global trends in hypertension prevalence, awareness, treatment, and control.Current opinion in nephrology and hypertension · 2026
    Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Ahmad AbrarNational Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Xiao HuBloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Jubaida AkhtarNational Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Shamim JubayerNational Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Mohammad Noor Nabi SayemEpidemiology, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Sarmin SultanaNational Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Mohammad Abdullah Al MamunNational Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Mahfuzur Rahman BhuiyanNational Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Fazila MalikCardiology, National Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh.
Mohammad Robed AminDirectorate General of Health Services, Dhaka, Bangladesh.
Abdul AlimDirectorate General of Health Services, Dhaka, Bangladesh.
Reena GuptaGeneral Medicine, University of California San Francisco, San Francisco, California, USA.
Di ZhaoBloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.ORCID 0000-0002-9978-6773
Margaret FarrellResolve to Saves Lives, New York, New York, USA.
Bolanle BanigbeResolve to Saves Lives, New York, New York, USA.
Kunihiro MatsushitaJohns Hopkins University, Baltimore, Maryland, USA.
Daniel BurkaResolve to Saves Lives, New York, New York, USA.
Lawrence AppelJohns Hopkins University, Baltimore, Maryland, USA.
Andrew E MoranResolve to Saves Lives, New York, New York, USA.ORCID 0000-0003-3554-0085
Sohel Reza ChoudhuryNational Heart Foundation Hospital and Research Institute, Dhaka, Bangladesh Sohel_r_choudhury@hotmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe World Health Organization (WHO) promotes the HEARTS technical package for improving hypertension control worldwide, but its effectiveness has not been rigorously evaluated.

objectiveTo compare hypertension outcomes in clinics implementing HEARTS versus clinics continuing usual hypertension care in rural Bangladesh.

methodsA matched-pair cluster quasi-experimental trial in Upazila Health Complexes (UHCs; primary healthcare facilities) was conducted in rural Bangladesh. A total of 3935 patients (mean age 52.3 years, 70.5% female) with uncontrolled hypertension (blood pressure (BP) ≥140/90 mm Hg regardless of treatment history) were enrolled: 1950 patients from 7 HEARTS UHCs and 1985 patients from 7 matched usual care UHCs. The primary outcome was systolic BP at 6 months measured at the patient's home; secondary outcomes were diastolic BP, hypertension control rate (<140/90 mm Hg) and loss to follow-up. Multivariable mixed-effects linear and Poisson models were conducted.

resultsBaseline mean systolic BP was 158.4 mm Hg in the intervention group and 158.8 mm Hg in the usual care group. At 6 months, 95.5% of participants completed follow-up. Compared with usual care, the intervention significantly lowered systolic BP (-23.7 mm Hg vs -20.0 mm Hg; net difference -3.7 mm Hg (95% CI -5.1 to -2.2)) and diastolic BP (-10.2 mm Hg vs -8.3 mm Hg; net difference -1.9 mm Hg (95% CI -2.7 to -1.1)) and improved hypertension control (62.0% vs 49.7%, net difference 12.3% (95% CI 9.0 to 16.8)). Rate of missed clinic visits was lower in the intervention group (8.8% vs 39.3%, p<0.001).

conclusionsAfter WHO-HEARTS package implementation in rural Bangladesh, BP was lowered and hypertension control improved significantly compared with usual care. TRIAL REGISTRATION NUMBER: NCT04992039.

Indexed as

HypertensionWorld Health OrganizationAdultAgedAntihypertensive AgentsBangladeshBlood PressureFemaleHumansMaleMiddle AgedTreatment OutcomeAntihypertensive Agentsglobal healthhypertension

Identifiers

PMID39019496
PMCPMC11347191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.